{
    "id": 553,
    "fullName": "AURKB W221L",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "AURKB W221L lies within the protein kinase domain of the Aurkb protein (UniProt.org). W221L has been demonstrated to confer Barasertib (AZD1152)-resistance in culture (PMID: 20935223), but has not been biochemically characterized and therefore, its effect on Aurkb protein function is unknown (PubMed, May 2018).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 46,
                    "pubMedId": 20935223,
                    "title": "Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20935223"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 9212,
        "geneSymbol": "AURKB",
        "terms": [
            "AURKB",
            "AIK2",
            "AIM-1",
            "AIM1",
            "ARK-2",
            "ARK2",
            "AurB",
            "aurkb-sv1",
            "aurkb-sv2",
            "IPL1",
            "PPP1R48",
            "STK-1",
            "STK12",
            "STK5"
        ]
    },
    "variant": "W221L",
    "createDate": "05/14/2014",
    "updateDate": "05/25/2018",
    "referenceTranscriptCoordinates": {
        "id": 112714,
        "transcript": "NM_004217",
        "gDna": "chr17:g.8206515C>A",
        "cDna": "c.662G>T",
        "protein": "p.W221L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7934,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AURKB W221L was detected as a secondary mutation in colon carcinoma cells with acquired resistance to Barasertib (AZD1152) in culture (PMID: 20935223).",
            "molecularProfile": {
                "id": 612,
                "profileName": "AURKB W221L"
            },
            "therapy": {
                "id": 662,
                "therapyName": "Barasertib",
                "synonyms": null
            },
            "indication": {
                "id": 1520,
                "name": "colon carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 46,
                    "pubMedId": 20935223,
                    "title": "Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20935223"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 242,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AMG 900 inhibited growth of an AZD1152-resistant colon carcinoma cell line harboring AURKB W221L in culture (PMID: 20935223).",
            "molecularProfile": {
                "id": 612,
                "profileName": "AURKB W221L"
            },
            "therapy": {
                "id": 983,
                "therapyName": "AMG 900",
                "synonyms": null
            },
            "indication": {
                "id": 1520,
                "name": "colon carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 46,
                    "pubMedId": 20935223,
                    "title": "Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20935223"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 612,
            "profileName": "AURKB W221L",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 112714,
            "transcript": "NM_004217",
            "gDna": "chr17:g.8206515C>A",
            "cDna": "c.662G>T",
            "protein": "p.W221L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112713,
            "transcript": "NM_001313950",
            "gDna": "chr17:g.8206515C>A",
            "cDna": "c.662G>T",
            "protein": "p.W221L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}